Voice-based heart failure detection that flags cardiac decompensation from a five-second daily recording.
Noah Labs Vox is a voice-based biomarker that detects worsening heart failure from a short voice recording. Fluid in the lungs changes the voice weeks before symptoms appear; Vox picks up that change and alerts the cardiology team so medication can be adjusted in time. It holds FDA Breakthrough Device Designation and has been validated in multi-center clinical trials with Mayo Clinic and Charité. The company, founded in Berlin in 2021, is headquartered in Boston and secured investment from BVP.
Vertical Applications
Vocal biomarkers, Remote patient monitoring
HQ COUNTRY
Germany
FOUNDED
2021
DEPLOYMENT
Cloud/SaaS, Mobile app
COMPANY STAGE
Seed
Is this your company? To claim this listing or update its details, contact us at sunil@uniocommunity.com
